User profiles for E. Sherman
Eric ShermanAssociate Attending, Memorial Sloan Kettering Cancer Center Verified email at mskcc.org Cited by 13983 |
Diagnostic criteria for malingered neurocognitive dysfunction: Proposed standards for clinical practice and research
DJ Slick, EMS Sherman, GL Iverson - The Clinical …, 1999 - Taylor & Francis
Over the past 10 years, widespread and concerted research efforts have led to increasingly
sophisticated and efficient methods and instruments for detecting exaggeration or fabrication …
sophisticated and efficient methods and instruments for detecting exaggeration or fabrication …
Neuropsychological outcomes after epilepsy surgery: systematic review and pooled estimates
EMS Sherman, S Wiebe, TB Fay‐McClymont… - …, 2011 - Wiley Online Library
Purpose: Epilepsy surgery is a safe surgical procedure, but it may be associated with cognitive
changes. Estimates of the risk of decline in specific neuropsychological domains after …
changes. Estimates of the risk of decline in specific neuropsychological domains after …
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review
Adenoid cystic carcinomas (ACC) are rare cancers usually arising in the salivary glands.
Once metastatic, the natural history can vary; some patients with indolent cancer remain …
Once metastatic, the natural history can vary; some patients with indolent cancer remain …
[BOOK][B] A compendium of neuropsychological tests: Administration, norms, and commentary
E Strauss, EMS Sherman, O Spreen - 2006 - books.google.com
… tion one could ever want on psychological tests can be found in test manuals on the office
shelves of most practicing neuropsychologists; the rest can be easily obtained via electronic …
shelves of most practicing neuropsychologists; the rest can be easily obtained via electronic …
Cycle-life model for graphite-LiFePO4 cells
J Wang, P Liu, J Hicks-Garner, E Sherman… - Journal of power …, 2011 - Elsevier
… A closer examination on the magnitudes of activation energy E a values revealed that we
could be fit the data if E a decreased with increasing C-rate. This trend allowed us to establish …
could be fit the data if E a decreased with increasing C-rate. This trend allowed us to establish …
Store environment and consumer purchase behavior: mediating role of consumer emotions
E Sherman, A Mathur, RB Smith - Psychology & Marketing, 1997 - Wiley Online Library
This article presents a large‐scale cross‐sectional field study of the effect of store environment
on consumer emotions and the resulting influence on aspects of consumer behavior with …
on consumer emotions and the resulting influence on aspects of consumer behavior with …
[HTML][HTML] Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study
…, FP Worden, MA Kane, E Sherman… - Journal of Clinical …, 2008 - ncbi.nlm.nih.gov
Purpose Patients with advanced, incurable thyroid cancer not amenable to surgery or
radioactive iodine (131 I) therapy have few satisfactory therapeutic options. This multi-institutional …
radioactive iodine (131 I) therapy have few satisfactory therapeutic options. This multi-institutional …
[HTML][HTML] Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
…, RK Grewal, R Leboeuf, EJ Sherman… - … England Journal of …, 2013 - Mass Medical Soc
Background Metastatic thyroid cancers that are refractory to radioiodine (iodine-131) are
associated with a poor prognosis. In mouse models of thyroid cancer, selective mitogen-…
associated with a poor prognosis. In mouse models of thyroid cancer, selective mitogen-…
[HTML][HTML] Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
LJ Wirth, E Sherman, B Robinson… - … England Journal of …, 2020 - Mass Medical Soc
Background RET mutations occur in 70% of medullary thyroid cancers, and RET fusions
occur rarely in other thyroid cancers. In patients with RET-altered thyroid cancers, the efficacy …
occur rarely in other thyroid cancers. In patients with RET-altered thyroid cancers, the efficacy …
[HTML][HTML] Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522
…, PF Nguyen-Tan, EJ Sherman… - Journal of clinical …, 2014 - ncbi.nlm.nih.gov
Purpose Combining cisplatin or cetuximab with radiation improves overall survival (OS) of
patients with stage III or IV head and neck carcinoma (HNC). Cetuximab plus platinum …
patients with stage III or IV head and neck carcinoma (HNC). Cetuximab plus platinum …